HIMS logo

HIMS

Hims & Hers Health Inc. Class A

$19.50
$0.00(0.00%)
35
Overall
20
Value
18
Tech
68
Quality
How is this score calculated?
Market Cap
$9.60B
Volume
20.81M
52W Range
$13.74 - $70.43
Target Price
$25.46

Company Overview

Mkt Cap$9.60BPrice$19.50
Volume20.81MChange+0.00%
P/E Ratio76.2Open$19.97
Revenue$1.5BPrev Close$19.50
Net Income$126.0M52W Range$13.74 - $70.43
Div YieldN/ATarget$25.46
Overall35Value20
Quality68Technical18

No chart data available

About Hims & Hers Health Inc. Class A

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Sector: Healthcare
Industry: Offices of Physicians, Mental Health Specialists

Latest News

Analysts’ Top Healthcare Picks: AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF)

Analysts fell to the sidelines weighing in on AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF) and Hims & Hers Health (HIMS) with neutral ratings, i...

Brian Anderson3 days ago

Analysts’ Top Healthcare Picks: AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF)

Brian Anderson3 days ago

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS) and Siemens Healthineers AG (OtherSEMHF)

Christine Brown12 days ago

HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise

Solomon Oladipupo13 days ago

Hims, Novo, CrowdStrike, SolarEdge, Telus Trending With Analysts

TipRanks Weekend Auto-Generated Newsdesk25 days ago
ABCD
1SymbolPriceChangeVol
2HIMS$19.500%20.81M
3
4
5
6

Get Hims & Hers Health Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.